{"schema_version":"secwatch.filing_event.v1","accession":"0001835268-25-000061","form_type":"8-K","ticker":"CNTB","cik":"0001835268","company_name":"Connect Biopharma Holdings Ltd","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.709523+00:00","generated_at":"2026-05-16T12:17:29.096852+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Connect Biopharma board member Kan Chen resigns amid U.S.-centric shift","bullets":["Kan Chen, Ph.D., partner at Qiming Venture Partners, resigned from Board and Nominating Committee effective Dec 17, 2025.","Resignation not due to any disagreement with company on operations, policies or practices.","Chen cited company's successful strategic shift to become more U.S.-centric as appropriate time to step down."],"urls":{"canonical":"https://secwatch.observer/filing/0001835268-25-000061","json":"https://secwatch.observer/filing/0001835268-25-000061.json","markdown":"https://secwatch.observer/filing/0001835268-25-000061.md","text":"https://secwatch.observer/filing/0001835268-25-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/0001835268-25-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/cntb-20251217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:17:29.096852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}